LAPADULA GIUSEPPE

Rugova, A., Ghilardi, G., Colella, E., Squillace, N., Cappelletti, A., Sabbatini, F., et al. (2025). Unexpected HBV reactivation following discontinuation of antiviral prophylaxis in immunosuppressed subjects with previous HBV exposure. In Abstracts from the 17° Italian Conference on AIDS and Antiviral Research (pp.145-146) [10.1136/sextrans-icar-2025.146]. Dettaglio

Mezzadri, L., Caramma, I., Sciabica, I., Migliorino, G., Cavallero, A., Marchetto, G., et al. (2025). Aspergillus Endocarditis: A Rare but Serious Complication During Treatment With Ibrutinib. CASE REPORT IN INFECTIOUS DISEASES, 2025(1), 1-6 [10.1155/crdi/6863015]. Dettaglio

Gagliardini, R., De Benedittis, S., Tavelli, A., Lapadula, G., Mazzotta, V., Bruzzesi, E., et al. (2025). Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 80(8), 2169-2178 [10.1093/jac/dkaf184]. Dettaglio

Cozzi-Lepri, A., Tavelli, A., Taramasso, L., Lapadula, G., Bobbio, N., Piconi, S., et al. (2025). Selected comorbidities and the probability of ART switch in PWH with undetectable HIV-RNA: a retrospective analysis in Italy. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 80(7), 1849-1859 [10.1093/jac/dkaf137]. Dettaglio

Ripamonti, D., Comi, L., Francavilla, A., Valenti, D., Cossu, M., Moschese, D., et al. (2025). Potential for replacing protease inhibitor with doravirine in cART-experienced subjects successfully treated with darunavir-cobicistat plus dolutegravir dual regimen. Intervento presentato a: 20th European AIDS Conference (EACS), Parigi. Dettaglio